Cargando…

Mean kinetic temperature evaluations through simulated temperature excursions and risk assessment with oral dosage usage for health programs

BACKGROUND: Temperature excursions occur during the transport and storage of pharmaceuticals, and often result in considerable losses for public health programs operating in countries with limited resources. After a temperature excursion has been identified, often products are discarded without any...

Descripción completa

Detalles Bibliográficos
Autores principales: Jenkins, David, Cancel, Aida, Layloff, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8842539/
https://www.ncbi.nlm.nih.gov/pubmed/35164726
http://dx.doi.org/10.1186/s12889-022-12660-9
_version_ 1784651068720807936
author Jenkins, David
Cancel, Aida
Layloff, Thomas
author_facet Jenkins, David
Cancel, Aida
Layloff, Thomas
author_sort Jenkins, David
collection PubMed
description BACKGROUND: Temperature excursions occur during the transport and storage of pharmaceuticals, and often result in considerable losses for public health programs operating in countries with limited resources. After a temperature excursion has been identified, often products are discarded without any additional risk assessments. Consulting the manufacturer is the preferred approach but can be challenging depending on the responsiveness of the manufacturer. However, decisions are often required quickly depending on program needs and available stock in country. METHODS: To provide further guidance, simulations have been conducted based on mean kinetic temperature evaluations using accepted default kinetic parameters to assess loss of shelf-life for scenarios involving various levels of temperature excursions on a model pharmaceutical at different recommended storage conditions, shelf-life, and long-term storage conditions. RESULTS: Although an immediate loss to shelf-life occurred with excursions when the product was stored at the maximum allowed temperature, more extended excursion could be withstood before loss of shelf-life was detected when long-term storage was maintained at temperatures below the maximum storage condition for the product. With the assumption that a shelf-life loss of 2 weeks was negligible when managing program stock, a risk assessment was conducted to outline the various times that excursions at different temperatures could be considered low risk to the program. CONCLUSIONS: Depending on the level of the temperature excursion and the guidance provided by the manufacturer, public health programs will have further information with this assessment to guide decisions that impact safety to the end user and resource management due to temperature excursions that can occur. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12889-022-12660-9.
format Online
Article
Text
id pubmed-8842539
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-88425392022-02-16 Mean kinetic temperature evaluations through simulated temperature excursions and risk assessment with oral dosage usage for health programs Jenkins, David Cancel, Aida Layloff, Thomas BMC Public Health Research BACKGROUND: Temperature excursions occur during the transport and storage of pharmaceuticals, and often result in considerable losses for public health programs operating in countries with limited resources. After a temperature excursion has been identified, often products are discarded without any additional risk assessments. Consulting the manufacturer is the preferred approach but can be challenging depending on the responsiveness of the manufacturer. However, decisions are often required quickly depending on program needs and available stock in country. METHODS: To provide further guidance, simulations have been conducted based on mean kinetic temperature evaluations using accepted default kinetic parameters to assess loss of shelf-life for scenarios involving various levels of temperature excursions on a model pharmaceutical at different recommended storage conditions, shelf-life, and long-term storage conditions. RESULTS: Although an immediate loss to shelf-life occurred with excursions when the product was stored at the maximum allowed temperature, more extended excursion could be withstood before loss of shelf-life was detected when long-term storage was maintained at temperatures below the maximum storage condition for the product. With the assumption that a shelf-life loss of 2 weeks was negligible when managing program stock, a risk assessment was conducted to outline the various times that excursions at different temperatures could be considered low risk to the program. CONCLUSIONS: Depending on the level of the temperature excursion and the guidance provided by the manufacturer, public health programs will have further information with this assessment to guide decisions that impact safety to the end user and resource management due to temperature excursions that can occur. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12889-022-12660-9. BioMed Central 2022-02-14 /pmc/articles/PMC8842539/ /pubmed/35164726 http://dx.doi.org/10.1186/s12889-022-12660-9 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Jenkins, David
Cancel, Aida
Layloff, Thomas
Mean kinetic temperature evaluations through simulated temperature excursions and risk assessment with oral dosage usage for health programs
title Mean kinetic temperature evaluations through simulated temperature excursions and risk assessment with oral dosage usage for health programs
title_full Mean kinetic temperature evaluations through simulated temperature excursions and risk assessment with oral dosage usage for health programs
title_fullStr Mean kinetic temperature evaluations through simulated temperature excursions and risk assessment with oral dosage usage for health programs
title_full_unstemmed Mean kinetic temperature evaluations through simulated temperature excursions and risk assessment with oral dosage usage for health programs
title_short Mean kinetic temperature evaluations through simulated temperature excursions and risk assessment with oral dosage usage for health programs
title_sort mean kinetic temperature evaluations through simulated temperature excursions and risk assessment with oral dosage usage for health programs
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8842539/
https://www.ncbi.nlm.nih.gov/pubmed/35164726
http://dx.doi.org/10.1186/s12889-022-12660-9
work_keys_str_mv AT jenkinsdavid meankinetictemperatureevaluationsthroughsimulatedtemperatureexcursionsandriskassessmentwithoraldosageusageforhealthprograms
AT cancelaida meankinetictemperatureevaluationsthroughsimulatedtemperatureexcursionsandriskassessmentwithoraldosageusageforhealthprograms
AT layloffthomas meankinetictemperatureevaluationsthroughsimulatedtemperatureexcursionsandriskassessmentwithoraldosageusageforhealthprograms